Note: Ingredients listed on restricted chemical lists
EC/CAS
265-157-1/64742-54-7
Name of the chemical
Distillates (petroleum), hydrotreated heavy paraffinic
Concentration
≥50
EC/CAS
265-169-7/64742-65-0
Name of the chemical
Distillates (petroleum), solvent-dewaxed heavy paraffinic
Concentration
1 - 3
General Information
Version
4.1
Revision date
2022-11-25
Product name
Eurol Ultrance VA 0W-30
Emergency telephone
+31 79 3467 808
Icons in SDS
Company Information
company name
Eurol bv. B.V
e-mail address of the competent person responsible for the Safety Data Sheet
reach@eurol.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H350
Hazard statements
Code
Statements
H350
May cause cancer
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Precautionary statements
P102 - Keep out of reach of children.
Supplemental label elements
EUH208 - Contains C14-16-18 Alkyl phenol. May produce an allergic reaction. EUH210 - Safety data sheet available on request. Child-resistant fastening : Not applicable Tactile warning : Not applicable
Other hazards which do not result in classification
This product floats on water and may affect the oxygen-balance in the water. The base oil contains less than 3% DMSO-extract measured according IP 346, therefore it is NOT classified as H350 May cause cancer" (Note L).". USED ENGINE OILS Combustion products resulting from the operation of internal combustion engines contaminate engine oils during use. Used engine oil may contain hazardous components which have the potential to cause skin cancer. Frequent or prolonged contact with all types and makes of used engine oil must therefore be avoided and a high standard of personal hygiene maintained. Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %